Hedge funds are actively enhancing their stakes in healthcare stocks, reflecting a significant trend in market behavior. With a notable surge in interest from both speculators and specialized funds, this sector is ripe for investment. The infusion of artificial intelligence into drug discovery is revolutionizing research capabilities, while the Food and Drug Administration's expedited approval processes further boost investor confidence.